An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide

UTSePress Research/Manakin Repository

Search UTSePress Research


Advanced Search

Browse

My Account

Show simple item record

dc.contributor.author Newton, Phillip en_US
dc.contributor.author Davidson, Patricia en_US
dc.contributor.author Sanderson, Christine en_US
dc.contributor.editor en_US
dc.date.accessioned 2012-10-12T03:34:32Z
dc.date.available 2012-10-12T03:34:32Z
dc.date.issued 2012 en_US
dc.identifier 2011003799 en_US
dc.identifier.citation Newton Phillip, Davidson Patricia, and Sanderson Christine 2012, 'An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide', BioMed Central, vol. 11, no. 6, en_US
dc.identifier.issn 1472-684X en_US
dc.identifier.other C1 en_US
dc.identifier.uri http://hdl.handle.net/10453/18701
dc.description.abstract Background: Off-label prescribing is common in palliative care. Despite inconsistent reports of the benefit of nebulised frusemide for breathlessness, its use continues to be reported. An online survey was emailed to 249 members of the Australian and New Zealand Society of Palliative Medicine to estimate the use of nebulised frusemide for breathlessness by Australian physicians involved in palliative care in the previous 12 months. There were 52/249 (21%) respondents to the survey. The majority (44/52; 85%) had not prescribed nebulised frusemide in the previous 12 months. The most common (18/44; 43%) reason for not prescribing nebulised frusemide was a belief that there was not enough evidence to support its use. Whilst only a few respondents (8/52; 15%) reported having used nebulised frusemide, all that had used it thought there was at least some benefit in relieving breathlessness. This report adds to the series of case studies reporting some benefit from nebulised frusemide in relieving breathlessnes. en_US
dc.language en_US
dc.publisher BioMed Central en_US
dc.title An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide en_US
dc.parent BMC Palliative Care en_US
dc.journal.volume 11 en_US
dc.journal.number 6 en_US
dc.publocation United Kingdom en_US
dc.identifier.startpage en_US
dc.identifier.startpage 1 en_US
dc.identifier.endpage en_US
dc.identifier.endpage 6 en_US
dc.cauo.name FOH.Faculty of Health en_US
dc.conference Verified OK en_US
dc.for 111000 en_US
dc.personcode 111808 en_US
dc.personcode 110950 en_US
dc.personcode 0000076398 en_US
dc.percentage 100 en_US
dc.classification.name Nursing en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US
dc.date.activity en_US
dc.location.activity en_US
dc.description.keywords Nebulised frusemide; Online survey; Off-label use en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record